Standard BioTools Inc. announced the appointment of Jeffrey Black as Senior Vice President effective May 15, 2023. Black will lead Standard BioTools' finance, accounting and investor relations functions, reporting to Michael Egholm, Ph.D., President and Chief Executive Officer. Vikram Jog will remain at the company for a period as Special Advisor to the CEO to ensure an effective transition.

Mr. Black was most recently Chief Financial Officer at Apollo Endosurgery Inc. until Apollo's acquisition by Boston Scientific in April 2023. Mr. Black has also served in senior finance leadership roles for seven publicly traded companies, including as Executive Vice President and Chief Financial Officer of Alphatec Holdings Inc., a medical technology company. Previously, Mr. Black was Chief Financial Officer of Applied Proteomics Inc., a proteomics-based diagnostics company, and as Chief Financial Officer of AltheaDx Inc., a pharmacogenetics diagnostics company.

Mr. Black began his career in the audit practice at EY. He is a member of the Board of Directors of Cellana Inc., an algae bioproducts company, and received his B.S. in Business from the University of Arizona.